KNIGHT THERAPEUTICS INC's ticker is KHTRF and the CUSIP is 499053106. A total of 2 filers reported holding KNIGHT THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $378,000 | -18.5% | 86,700 | 0.0% | 0.58% | -24.5% |
Q2 2020 | $464,000 | +19.6% | 86,700 | 0.0% | 0.77% | +46.7% |
Q1 2020 | $388,000 | -45.0% | 86,700 | -27.9% | 0.52% | -32.8% |
Q4 2019 | $705,000 | -61.4% | 120,229 | -63.0% | 0.78% | -62.7% |
Q3 2019 | $1,826,000 | -15.9% | 324,979 | -12.2% | 2.08% | +11.4% |
Q2 2019 | $2,172,000 | +6.9% | 369,979 | 0.0% | 1.87% | +1.8% |
Q1 2019 | $2,031,000 | -4.1% | 369,979 | -0.3% | 1.84% | -11.8% |
Q4 2018 | $2,118,000 | -12.0% | 370,950 | -2.6% | 2.08% | +12.5% |
Q3 2018 | $2,408,000 | -2.7% | 380,950 | -5.6% | 1.85% | -11.6% |
Q2 2018 | $2,475,000 | -99.9% | 403,700 | -1.2% | 2.10% | -6.1% |
Q1 2018 | $2,456,777,000 | -7.5% | 408,700 | 0.0% | 2.23% | -3.2% |
Q4 2017 | $2,656,141,000 | -7.3% | 408,700 | -1.3% | 2.30% | -13.1% |
Q3 2017 | $2,864,081,000 | -12.9% | 414,100 | 0.0% | 2.65% | -21.0% |
Q2 2017 | $3,290,025,000 | +2.5% | 414,100 | +0.5% | 3.36% | -0.3% |
Q1 2017 | $3,210,506,000 | -1.6% | 412,100 | 0.0% | 3.37% | -12.1% |
Q4 2016 | $3,263,832,000 | +42.4% | 412,100 | +29.7% | 3.83% | +22.3% |
Q3 2016 | $2,292,355,000 | +11.5% | 317,800 | -1.2% | 3.13% | +17.7% |
Q2 2016 | $2,056,624,000 | +5.6% | 321,800 | +0.8% | 2.66% | +20.3% |
Q1 2016 | $1,947,701,000 | +9.4% | 319,400 | -1.8% | 2.21% | +9.6% |
Q4 2015 | $1,780,849,000 | +5.0% | 325,400 | +5.5% | 2.02% | +24.6% |
Q3 2015 | $1,695,275,000 | – | 308,400 | – | 1.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCOUNT MANAGEMENT LLC | 308,400 | $1,695,275,000 | 1.62% |
Cove Street Capital, LLC | 100,000 | $550,000 | 0.07% |